Hepion Pharmaceuticals's total assets for Q4 2025 were $3.07M, a decrease of -17.92% from the previous quarter. HEPA total liabilities were $402.40K for the fiscal quarter, a -3.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.